Literature DB >> 10524841

CT evaluation of hepatic injury following proton beam irradiation: appearance, enhancement, and 3D size reduction pattern.

T Ahmadi1, Y Itai, H Onaya, H Yoshioka, T Okumura, Y Akine.   

Abstract

PURPOSE: The purpose of this study was to investigate the long-term imaging appearances of hepatic injury following proton beam irradiation. The time-attenuation curves, time of appearance and recovery, and 3D size reduction pattern are described in patients of different ages and genders with different irradiation doses, irradiated portals, and Child groups.
METHOD: Forty-six patients with hepatocellular carcinoma underwent 50 to 84 Gy proton beam irradiation in periods of 14-52 days. CT including noncontrast and dynamic study was performed every 3 months starting 3 weeks after the end of irradiation. The 3D volume measurement of areas of radiation-induced hepatic injury was performed through incremental dynamic CT images in every follow-up study. CT follow-up study of the patients was done for 12-76 months.
RESULTS: Radiation-induced hepatic injury was observed as low attenuation areas on noncontrast CT and enhanced areas on dynamic study in the regions corresponding to the irradiation portals. Of our cases, 67.5% showed the appearance of radiation hepatitis in 3-4 weeks and 95.3% in 3-4 months after the end of irradiation. In both periods, there was a significant delay in the female patients. The time-attenuation curve showed an early and prolonged enhancement of the irradiated regions. The volume reduction pattern of the injured areas was found to be longstanding, exponential, and directed from periphery to the center.
CONCLUSION: Early appearance of radiation-induced hepatic injury was found only to be gender dependent, with a tendency to occur with higher irradiated doses; no other parameters affected this phenomenon in our cases. Disappearance of the injured areas, if present, takes a long time (at least 42 months).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10524841     DOI: 10.1097/00004728-199909000-00002

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  8 in total

1.  Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound--initial results.

Authors:  M Krix; C Plathow; M Essig; K Herfarth; J Debus; H-U Kauczor; S Delorme
Journal:  Eur Radiol       Date:  2005-02-24       Impact factor: 5.315

2.  FDG-Avid Focal Liver Reaction From Proton Therapy in a Patient With Primary Esophageal Adenocarcinoma.

Authors:  Hena S Ahmed; Austin R Pantel; James M Metz; John P Plastaras; Michael D Farwell
Journal:  Clin Nucl Med       Date:  2018-05       Impact factor: 7.794

3.  CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function.

Authors:  N Sanuki-Fujimoto; A Takeda; T Ohashi; E Kunieda; S Iwabuchi; K Takatsuka; N Koike; N Shigematsu
Journal:  Br J Radiol       Date:  2010-12       Impact factor: 3.039

4.  Time-dependent changes in CT of radiation-induced liver injury: a preliminary study in gastric cancer patients.

Authors:  Yaqi Sheng; Qiuxia Wang; Zhen Li; Nannan Zheng; Yigang Pei; Liang Chen; Dayu Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

5.  Registration error of the liver CT using deformable image registration of MIM Maestro and Velocity AI.

Authors:  Nobuyoshi Fukumitsu; Kazunori Nitta; Toshiyuki Terunuma; Toshiyuki Okumura; Haruko Numajiri; Yoshiko Oshiro; Kayoko Ohnishi; Masashi Mizumoto; Teruhito Aihara; Hitoshi Ishikawa; Koji Tsuboi; Hideyuki Sakurai
Journal:  BMC Med Imaging       Date:  2017-05-04       Impact factor: 1.930

6.  Indicator for local recurrence of hepatocellular carcinoma after proton beam therapy: analysis of attenuation difference between the irradiated tumor and liver parenchyma on contrast enhancement CT.

Authors:  Hiroaki Takahashi; Yuta Sekino; Kensaku Mori; Toshiyuki Okumura; Katsuhiro Nasu; Kuniaki Fukuda; Sota Masuoka; Takashi Iizumi; Naoyuki Hasegawa; Hideyuki Sakurai; Manabu Minami
Journal:  Br J Radiol       Date:  2019-11-07       Impact factor: 3.039

7.  Stereotactic body radiotherapy-induced arterial hypervascularity of non-tumorous hepatic parenchyma in patients with hepatocellular carcinoma: potential pitfalls in tumor response evaluation on multiphase computed tomography.

Authors:  Mee Jin Park; So Yeon Kim; Sang Min Yoon; Jong Hoon Kim; Seong Ho Park; Seung Soo Lee; Yedaun Lee; Moon-Gyu Lee
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

8.  Tumor Contrast-Enhancement for Monitoring of PRRT 177Lu-DOTATATE in Pancreatic Neuroendocrine Tumor Patients.

Authors:  Olof Pettersson; Katarzyna Fröss-Baron; Joakim Crona; Anders Sundin
Journal:  Front Oncol       Date:  2020-02-21       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.